Read the NPHC 10Q. Motivation for PR and other things easier to see. I will do a side by side comparison with XCHO 10Q in another post.
There are some negative things in the NPHC for XCHO. Two that pop out is that NPHC is going to run out of money fairly soon, and they say so in the 10Q, unless they bring in more money. That has been going on for years, so at least they have a track record of bringing in more money. The 2nd is that they indicate they have plans to go into competition with their own exclusive distributor (XCHO) with the same product just a dose increase. This relates to the first point that NPHC is not doing well financially. This would seem to violate the contract and partner etiquette.
But after reading both I am more positive on XCHO that was before reading the two 10Qs. They have problems, it is not as rosy as it looks after the 1Q. But it does appear possible they can make the RedChip #s.